Lupin share price opened at ₹2090 today and hit a high of ₹2166.90, the closing price of the share was ₹2162.85 Lupin is a pharmaceutical company. The market cap of Luin company is 95760.43 crores. Today, in the trading session of 19 December, Lupin share price has increased by ₹63.75
Lupin a leading Indian pharmaceutical company, has received a significant boost after securing approval from the US Food and Drug Administration (FDA) for its generic version of Gilead Sciences’ HIV drug, Descovy. The approved product, Emtricitabine and Tenofovir Alafenamide Tablets (200 mg/25 mg), will be manufactured at Lupin’s Nagpur facility in India.
This milestone grants Lupin 180 days of shared exclusivity in the US market, providing a competitive edge in the lucrative generic drug segment. The approval marks a critical step in Lupin’s expansion in the global HIV treatment
market, as it becomes one of the first companies to launch a generic version of Descovy.Following the announcement, Lupin’s stock price rise by 2%, reflecting investor confidence in the company’s growth prospects and its ability to deliver innovative solutions in the pharmaceutical space.
Lupin share price in 2025
Lupin share price can touch the level of ₹2900 to ₹3000 in 2025. Lupin share has broken out of double bottom pattern with high volume today. Apart from this, Lupin share price is also breaking a trend line, good money can be made in the breakout.
Lupin share price action
Lupin share price has broken out of double bottom pattern with high volume, along with this it has also broken a trend line. Lupin share in 2025 There is a possibility of touching the level of ₹ 3000
Disclaimer
This information is for educational purpose only. Before investing and trading, you must take advice from your financial advisor.